Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033066 · ClinicalTrials.gov registry record · NA
Financial Incentives and Recruitment to the APT Webstudy
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 44,844
- Enrollment target
NCT06033066 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 44,844 participants.
The verdict
NCT06033066, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 44,844 participants
- Enrollment target
Study Summary
This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cognitive testing using validated platforms. The APT Webstudy implements fully remote assessments, coordinated by the Alzheimer's Therapeutic Research Institute (ATRI) under USC IRB #HS-17-00746. The purpose of the current study is to test whether we can increase enrollment of diverse individuals into the registry. To do this, we will work with Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers in Contra Costa County, California, to test whether sending messages with and without financial incentives to patients who receive primary care with the health system can increase enrollment to the APT Webstudy. The investigators hypothesize that 1) a certain small financial incentive and an award opportunity based incentive (or a drawing with a prize) will increase enrollment rates of CCHS members into the APT Webstudy relative to the control group. The investigators further hypothesize that the award opportunity incentive will increase the enrollment rate of CCRMC patients into the APT Webstudy more than a certain financial incentive with the same expected value.
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44,844 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06033066
The ClinicalTrials.gov registry entry for NCT06033066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44,844 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Financial Incentives is the first listed.
NCT06033066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06033066 about?
NCT06033066 is a clinical study titled "Financial Incentives and Recruitment to the APT Webstudy". This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cogni...
What is the current status of trial NCT06033066?
This trial is currently completed. It is a NA study. The enrollment target is 44,844 participants. The study started on 2024-03-01. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT06033066?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033066?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.